| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/26/2001 | EP1136548A1 Novel trypsin family serine proteases |
| 09/26/2001 | EP1136547A2 Adamts polypeptides, nucleic acids encoding them, and uses thereof |
| 09/26/2001 | EP1136504A1 Receptor for Latrotoxin from insects |
| 09/26/2001 | EP1136503A1 Novel physiologically active substance, process for producing the same and utilization thereof |
| 09/26/2001 | EP1136502A1 Insect ligand-gated anion channels |
| 09/26/2001 | EP1136501A2 Receptors for peptides from insect origin |
| 09/26/2001 | EP1136500A2 Seroreactive regions from the HPV proteins E1 and E2 |
| 09/26/2001 | EP1135982A1 Method of constructing male sterile plant |
| 09/26/2001 | EP1135688A2 Methods and compositions useful for targeting activated vitronectin receptor alpha(nu)-beta(3) |
| 09/26/2001 | EP1135681A1 Three-hybrid screening method for ligand-protein interactions |
| 09/26/2001 | EP1135535A2 Development of anti-microbial agents based on bacteriophage genomics |
| 09/26/2001 | EP1135534A1 Use of factor x polymorphism in the diagnosis and treatment of factor x and/or factor xa mediated diseases |
| 09/26/2001 | EP1135533A1 Method and system for detecting oligonucleotides in a sample |
| 09/26/2001 | EP1135532A1 Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof |
| 09/26/2001 | EP1135531A1 Methods for introducing heterologous cells into fish |
| 09/26/2001 | EP1135530A2 Multiplex amplification of short tandem repeat loci |
| 09/26/2001 | EP1135529A1 Determining signal transduction pathways |
| 09/26/2001 | EP1135528A2 Length determination of nucleic acid repeat sequences by discontinuous primer extension |
| 09/26/2001 | EP1135527A2 Cloning and copying on surfaces |
| 09/26/2001 | EP1135526A2 Method for identifying cytosine methylation patterns in genomic dna |
| 09/26/2001 | EP1135524A1 Array and method for analysing nucleic acid sequences |
| 09/26/2001 | EP1135522A2 Method for determining nucleotide sequences using arbitrary primers and low stringency |
| 09/26/2001 | EP1135518A1 Transgenic animals as urinary bioreactors for the production of protein in the urine, recombinant dna construct for kidney-specific expression, and method of using same |
| 09/26/2001 | EP1135516A1 Use of an immuno complex for the preparation of a therapeutic composition useful for transfecting a polynucleotide into macropinocyte cells |
| 09/26/2001 | EP1135515A2 Use of trans-activation and cis-activation to modulate the persistence of expression of a transgene |
| 09/26/2001 | EP1135514A1 E1b-deleted adenoviral shuttle vectors |
| 09/26/2001 | EP1135513A1 Adenovirus-mediated gene therapy |
| 09/26/2001 | EP1135512A1 Artificial matrix attachment region for increasing expression of genes introduced in plant cells |
| 09/26/2001 | EP1135511A1 Phosphonate metabolizing plants |
| 09/26/2001 | EP1135510A2 Dna sequence encoding a glutamate/malate translocator, plasmids, bacteria, yeasts and plants containing said transporter |
| 09/26/2001 | EP1135509A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 09/26/2001 | EP1135508A2 Plant 1-deoxy-d-xylulose 5-phosphate synthase |
| 09/26/2001 | EP1135507A1 Fruit flavour related genes and use thereof |
| 09/26/2001 | EP1135506A2 Cytochrome p450 monooxygenase and nadph cytochrome p450 oxidoreductase genes and proteins related to the omega hydroxylase complex of candida tropicalis and methods relating thereto |
| 09/26/2001 | EP1135504A2 Human ubiquitin ligase e3 for the modulation of nf-kappa b |
| 09/26/2001 | EP1135503A2 DRUG TARGETS IN $i(CANDIDA ALBICANS) |
| 09/26/2001 | EP1135502A1 ISOLATION AND CHARACTERIZATION OF A $i(N. CRASSA) SILENCING GENE AND USES THEREOF |
| 09/26/2001 | EP1135501A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 09/26/2001 | EP1135500A1 Control of flowering |
| 09/26/2001 | EP1135499A1 Dna sequences which code a glucose-translocator, plasmids, bacteria, yeasts and plants containing this translocator |
| 09/26/2001 | EP1135498A1 Antibody variants with higher binding affinity compared to parent antibodies |
| 09/26/2001 | EP1135497A1 Polypeptides capable of interacting with the human topoisomerase iii alpha |
| 09/26/2001 | EP1135496A2 Ucp5 |
| 09/26/2001 | EP1135495A2 Secreted amd transmembrane polypeptides and nucleic acids encoding the same |
| 09/26/2001 | EP1135494A2 Neuron-associated proteins |
| 09/26/2001 | EP1135492A1 12216 receptor, a g-protein coupled receptor |
| 09/26/2001 | EP1135491A2 Methods and compositions for inhibiting neoplastic cell growth |
| 09/26/2001 | EP1135490A1 Human vanilloid receptors and their uses |
| 09/26/2001 | EP1135489A1 Pth1r and pth3r receptors |
| 09/26/2001 | EP1135488A1 Human semaphorin 6a-1 (sema6a-1), a gene involved in neuronal development and regeneration mechanisms during apoptosis, and its use as a potential drug target |
| 09/26/2001 | EP1135487A2 Scorpion toxins |
| 09/26/2001 | EP1135486A1 RECOMBINANT SOLUBLE Fc RECEPTORS |
| 09/26/2001 | EP1135485A2 Promotion or inhibition of angiogenesis and cardiovascularization |
| 09/26/2001 | EP1135484A2 Gtpase associated proteins |
| 09/26/2001 | EP1135483A2 Cytokine signal regulators |
| 09/26/2001 | EP1135482A1 Cancer cell vaccine |
| 09/26/2001 | EP1135481A1 New oligomeric conjugates liable to transfer biological molecules into cells |
| 09/26/2001 | EP1135480A1 Promoters for gene expression in the roots of plants |
| 09/26/2001 | EP1135479A1 Formulations and methods for isolating nucleic acids from any complex starting material and subsequent complex genetic analysis |
| 09/26/2001 | EP1135478A1 Activated cation channel of the osteoblast as a mechanism of bone anabolism |
| 09/26/2001 | EP1135477A1 Humanized monoclonal antibodies |
| 09/26/2001 | EP1135474A2 FATTY ACYL-CoA: FATTY ALCOHOL ACYLTRANSFERASES |
| 09/26/2001 | EP1135472A2 UDP-N- ACETYL GLUCOSAMINE: GALACTOSE-BETA1, 3-N- ACETYL GALACTOSAMINE-ALPHA-R/ N- ACETYL GLUCOSAMINE -BETA1, 3-N- ACETYL GALACTOSAMINE- ALPHA-R (GlcNAc TO GalNAc) BETA1, 6-N- ACETYL GLUCOSAMINYL TRANSFERASE, C2/4GnT |
| 09/26/2001 | EP1135470A2 Recombinant methods and materials for producing epothilone and epothilone derivatives |
| 09/26/2001 | EP1135469A1 An improved method for the production and purification of adenoviral vectors |
| 09/26/2001 | EP1135468A1 Virus vectors and methods of making and administering the same |
| 09/26/2001 | EP1135467A1 Psca: prostate stem cell antigen and uses thereof |
| 09/26/2001 | EP1135461A1 Gene networks for control of gene expression |
| 09/26/2001 | EP1135415A1 Humanized antibodies to gamma-interferon |
| 09/26/2001 | EP1135413A2 Proteins that bind angiogenesis-inhibiting proteins, compoisitions and methods of use thereof |
| 09/26/2001 | EP1135412A2 Tumor necrosis factor receptor homologue-1 (trh1) |
| 09/26/2001 | EP1135410A2 Antennapedia homeodomain helix 3 derived translocation vectors |
| 09/26/2001 | EP1135409A1 Decorin binding proteins dbp a and b and genes encoding them |
| 09/26/2001 | EP1135407A1 Ring finger protein zapop3 |
| 09/26/2001 | EP1135402A1 Antisense modulation of egr-1 expression |
| 09/26/2001 | EP1135158A2 Enhanced vaccines |
| 09/26/2001 | EP1135153A1 Uses for eph receptor antagonists and agonists to treat vascular disorders |
| 09/26/2001 | EP1135149A1 Pgc-1, a novel brown fat ppar gamma coactivator |
| 09/26/2001 | EP1135144A1 Compositions and methods for regulating bacterial pathogenesis |
| 09/26/2001 | EP1135113A1 Treatment of parkinson's disease with oligonucleotides |
| 09/26/2001 | EP1135025A1 Plasmid maintenance system for antigen delivery |
| 09/26/2001 | EP1135022A1 Plastin promoter directed gene therapy |
| 09/26/2001 | EP0932664B1 A cell-free system for initiation of dna replication |
| 09/26/2001 | EP0923597B1 Substituted propargylethoxyamido nucleosides |
| 09/26/2001 | EP0920537A4 Method for chromosomes classification |
| 09/26/2001 | EP0912239B1 Method for providing dense particle compositions for use in transdermal particle delivery |
| 09/26/2001 | EP0909313A4 Methods for creating transgenic animals |
| 09/26/2001 | EP0904362A4 Method for transforming plant tissue |
| 09/26/2001 | EP0859792B1 Tryptase polyclonal antibody and purification method for use in human tryptase immunoassay |
| 09/26/2001 | EP0831931A4 An in vivo and in vitro model of cutaneous photoaging |
| 09/26/2001 | EP0804581B1 Compounds and methods for the stimulation and enhancement of protective immune responses and il-12 production |
| 09/26/2001 | EP0771325B1 Process for modifying the stability of antibodies |
| 09/26/2001 | EP0767796B1 Chemotactic protein |
| 09/26/2001 | EP0725778B1 Recombinant production of novel polyketides |
| 09/26/2001 | EP0707591B1 Methylphosphonic acid ester, process for preparing the same and its use |
| 09/26/2001 | EP0672191B1 Quantitative detection of macromolecules with fluorescent oligonucleotides |
| 09/26/2001 | EP0592597B1 Novel mutagenesis methods and compositions |
| 09/26/2001 | EP0495910B1 Production and use of human nm23-h2 protein and antibodies therefor |
| 09/26/2001 | CN1315000A Methods for determining presence of cancer in a sample by determining expression of an ssx gene, peptide derived from said ssx gene and NY-ESO-1 gene, and uses thereof |
| 09/26/2001 | CN1314953A Method and compositions to identify swine genetically resistant to F18 E. coli associated diseases |